Medidata Solutions, Inc. Stock, NASDAQ:MDSO
350 HUDSON ST., 9TH FLOOR, NEW YORK, NY 10014
United States of America
Number of Employees: 1424
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. The company's platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments. Its platform solutions also comprise Engage Patients that captures the voice of the patient in clinical studies; Medidata Patient Cloud, which enables sponsors to collect a dataset directly from the patient; Conduct Study that includes solutions for data capture and study management in the clinical trial research process; Medidata RaveX, an electronic data capture and management system solution; Study Management that enable clinical teams to manage, monitor, control, integrate, and report operational and clinical data from patients and sites; and Optimize Outcomes, which is designed to surface a range of embedded operational data across the clinical process. Additionally, it offers professional services. The company markets and sells its cloud-based solutions through a direct sales force, as well as through relationships with contract research organizations (CROs) and other strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and CROs and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.